Chairman Zhang Shuguang of the board of directors reduced his holdings of Huakang Biomed (08622) by approximately 139 million shares, with an average selling price of around HKD 0.12 per share.
On January 10, the chairman of the board, Zhang Shuguang, reduced his holding of Huakang Biomedical (08622) by 138,672,000 shares, at a price of 0.1175 Hong Kong dollars per share, for a total amount of 16.29396 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on January 10th, Chairman Zhang Shuguang of the board of directors reduced his holdings of HUAKANG BIOMED (08622) by 138.672 million shares, with a price of HKD 0.1175 per share, totaling 16.29396 million Hong Kong dollars. After the reduction, the latest number of shares held is 4 million shares, and the latest shareholding ratio is 0.8%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
